BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9745197)

  • 21. Serum visfatin levels in late pregnancy and pre-eclampsia.
    Hu W; Wang Z; Wang H; Huang H; Dong M
    Acta Obstet Gynecol Scand; 2008; 87(4):413-8. PubMed ID: 18382866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy-associated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester.
    Deveci K; Sogut E; Evliyaoglu O; Duras N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):94-8. PubMed ID: 19215554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.
    Bayhan G; Koçyigit Y; Atamer A; Atamer Y; Akkus Z
    Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mean platelet volume of normal pregnant women and severe preeclamptic women in Siriraj Hospital.
    Boriboonhirunsarn D; Atisook R; Taveethamsathit T
    J Med Assoc Thai; 1995 Nov; 78(11):586-9. PubMed ID: 8576668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antithrombin III in normal pregnancy and late toxicoses].
    Kholevich B; Kamenov V
    Akush Ginekol (Sofiia); 1984; 23(4):306-9. PubMed ID: 6486368
    [No Abstract]   [Full Text] [Related]  

  • 26. Longitudinal determination of serum placental protein 13 during development of preeclampsia.
    Huppertz B; Sammar M; Chefetz I; Neumaier-Wagner P; Bartz C; Meiri H
    Fetal Diagn Ther; 2008; 24(3):230-6. PubMed ID: 18753763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum advanced oxidation protein products, myeloperoxidase and ascorbic acid in pre-eclampsia and eclampsia.
    Noyan T; Güler A; Sekeroğlu MR; Kamaci M
    Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):486-91. PubMed ID: 17116052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood coagulation in pregnancy induced hypertension.
    Weenink GH; ten Cate JW; Treffers PE; Smorenberg-Schoorl ME
    Scand J Clin Lab Invest Suppl; 1985; 178():99-105. PubMed ID: 3867126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [C-reactive protein in women with pre-eclampsia].
    Batashki I; Milchev N; Topalovska D; Uchikova E; Mateva N
    Akush Ginekol (Sofiia); 2006; 45 Suppl 1():47-50. PubMed ID: 16673658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes of plasma fibronectin and antithrombin III in pregnancy-induced hypertension].
    Tong Y
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):6-8, 60. PubMed ID: 2004575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of fibrinogen and C-reactive protein with severity of preeclampsia.
    Ustün Y; Engin-Ustün Y; Kamaci M
    Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):154-8. PubMed ID: 16054955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low plasma levels of oxidized low density lipoprotein in preeclampsia.
    Raijmakers MT; van Tits BJ; Hak-Lemmers HL; Roes EM; Steegers EA; Peters WH
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1173-7. PubMed ID: 15548151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibronectin as a predictor of preeclampsia: a pilot study.
    Jones I; Cowley D; Andersen M; Vacca A; Voroteliak V
    Aust N Z J Obstet Gynaecol; 1996 Feb; 36(1):1-3. PubMed ID: 8775238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of leukocyte functional antigen-3 in pregnancy and preeclampsia.
    Hefler L; Kainz C; Zeisler H; Heinze G; Schatten C; Husslein P; Leodolter S; Tempfer C
    Acta Obstet Gynecol Scand; 1999 Aug; 78(7):580-5. PubMed ID: 10422903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of serum leptin level as a marker of severity of pre eclampsia.
    Mumtaz F; Memon AR; Yousfani S; Tahir SM; Khushk I; Memon M; Memon A
    J Ayub Med Coll Abbottabad; 2008; 20(1):13-5. PubMed ID: 19024177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preliminary report of plasma antithrombin III in pregnant women].
    Ding ML
    Zhonghua Fu Chan Ke Za Zhi; 1987 May; 22(3):157-8, 190. PubMed ID: 3652811
    [No Abstract]   [Full Text] [Related]  

  • 37. Maternal erythrocyte malondialdehyde level in preeclampsia prediction: a longitudinal study.
    Basbug M; Demir I; Serin IS; Ozcelik B; Saraymen R; Narin F; Tayyar M
    J Perinat Med; 2003; 31(6):469-74. PubMed ID: 14711102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Usefulness of standard clotting and fibrinolysis tests for evaluation of hemostatic balance in women during the III trimester of pregnancy with slight and moderate preeclampsia].
    Starzewski J; Niespodziański K; Plutecki J; Polak G; Piasek G; Gutowski J
    Przegl Lek; 1996; 53(2):83-7. PubMed ID: 8754327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemostatic abnormalities in patients with severe preeclampsia.
    Heilmann L; Rath W; Pollow K
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):285-91. PubMed ID: 17636190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markers of inflammation in preeclampsia.
    Fialová L; Kalousová M; Soukupová J; Malbohan I; Madar J; Frisová V; Stípek S; Zima T
    Prague Med Rep; 2004; 105(3):301-10. PubMed ID: 15782556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.